| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |